Cargando…
Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia
BACKGROUND: Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases (endopeptidases) whose catalytic action is the degradation of the extracellular matrix components. In addition, they play the major role in the degradation of collagen and in the process of tissue remodeling...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774681/ https://www.ncbi.nlm.nih.gov/pubmed/19886986 http://dx.doi.org/10.1186/1749-8090-4-59 |
_version_ | 1782173966397341696 |
---|---|
author | Karapanagiotidis, Georgios T Antonitsis, Polychronis Charokopos, Nicholas Foroulis, Christophoros N Anastasiadis, Kyriakos Rouska, Efthymia Argiriadou, Helena Rammos, Kyriakos Papakonstantinou, Christos |
author_facet | Karapanagiotidis, Georgios T Antonitsis, Polychronis Charokopos, Nicholas Foroulis, Christophoros N Anastasiadis, Kyriakos Rouska, Efthymia Argiriadou, Helena Rammos, Kyriakos Papakonstantinou, Christos |
author_sort | Karapanagiotidis, Georgios T |
collection | PubMed |
description | BACKGROUND: Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases (endopeptidases) whose catalytic action is the degradation of the extracellular matrix components. In addition, they play the major role in the degradation of collagen and in the process of tissue remodeling. The present clinical study investigated blood serum levels of metalloproteinases- 1, -2, -3 and -9 in patients with acute and chronic aortic dissection, thoracic aortic aneurysm and acute myocardial ischemia compared to healthy individuals. METHODS: The blood serum levels of MMP-1, -2, -3 and -9 were calculated in 31 patients with acute aortic dissection, 18 patients with chronic aortic dissection, 18 patients with aortic aneurysm and in 13 patients with acute myocardial ischemia, as well as in 15 healthy individuals who served as the control group. Serum MMP levels were measured by using an ELISA technique. RESULTS: There were significantly higher levels of MMP-3 in patients with acute myocardial ischemia as compared to acute aortic dissection (17.33 ± 2.03 ng/ml versus 12.92 ± 1.01 ng/ml, p < 0.05). Significantly lower levels of MMP-1 were found in healthy controls compared to all groups of patients (1.1 ± 0.38 ng/ml versus 2.97 ± 0.68 in acute aortic dissection, 3.09 ± 0.98 in chronic dissection, 3.16 ± 0.51 in thoracic aortic aneurysm and 4.58 ± 1.04 in acute myocardial ischemia, p < 0.05). Higher levels of MMP-1 and MMP-3 were detected on males. There was a positive correlation with increasing age (r = 0.38, p < 0.05). In patients operated for acute type A aortic dissection, the levels of MMP-1, MMP-3 and MMP-9 increased immediately after surgery, while the levels of MMP-2 decrease. At 24 hours postoperatively, levels of MMP -1, -2 and -9 are almost equal to the preoperative ones. CONCLUSION: Measurement of serum MMP levels in thoracic aortic disease and acute myocardial ischemia is a simple and relatively rapid laboratory test that could be used as a biochemical indicator of aortic disease or acute myocardial ischemia, when evaluated in combination with imaging techniques. |
format | Text |
id | pubmed-2774681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27746812009-11-10 Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia Karapanagiotidis, Georgios T Antonitsis, Polychronis Charokopos, Nicholas Foroulis, Christophoros N Anastasiadis, Kyriakos Rouska, Efthymia Argiriadou, Helena Rammos, Kyriakos Papakonstantinou, Christos J Cardiothorac Surg Research Article BACKGROUND: Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent proteases (endopeptidases) whose catalytic action is the degradation of the extracellular matrix components. In addition, they play the major role in the degradation of collagen and in the process of tissue remodeling. The present clinical study investigated blood serum levels of metalloproteinases- 1, -2, -3 and -9 in patients with acute and chronic aortic dissection, thoracic aortic aneurysm and acute myocardial ischemia compared to healthy individuals. METHODS: The blood serum levels of MMP-1, -2, -3 and -9 were calculated in 31 patients with acute aortic dissection, 18 patients with chronic aortic dissection, 18 patients with aortic aneurysm and in 13 patients with acute myocardial ischemia, as well as in 15 healthy individuals who served as the control group. Serum MMP levels were measured by using an ELISA technique. RESULTS: There were significantly higher levels of MMP-3 in patients with acute myocardial ischemia as compared to acute aortic dissection (17.33 ± 2.03 ng/ml versus 12.92 ± 1.01 ng/ml, p < 0.05). Significantly lower levels of MMP-1 were found in healthy controls compared to all groups of patients (1.1 ± 0.38 ng/ml versus 2.97 ± 0.68 in acute aortic dissection, 3.09 ± 0.98 in chronic dissection, 3.16 ± 0.51 in thoracic aortic aneurysm and 4.58 ± 1.04 in acute myocardial ischemia, p < 0.05). Higher levels of MMP-1 and MMP-3 were detected on males. There was a positive correlation with increasing age (r = 0.38, p < 0.05). In patients operated for acute type A aortic dissection, the levels of MMP-1, MMP-3 and MMP-9 increased immediately after surgery, while the levels of MMP-2 decrease. At 24 hours postoperatively, levels of MMP -1, -2 and -9 are almost equal to the preoperative ones. CONCLUSION: Measurement of serum MMP levels in thoracic aortic disease and acute myocardial ischemia is a simple and relatively rapid laboratory test that could be used as a biochemical indicator of aortic disease or acute myocardial ischemia, when evaluated in combination with imaging techniques. BioMed Central 2009-11-03 /pmc/articles/PMC2774681/ /pubmed/19886986 http://dx.doi.org/10.1186/1749-8090-4-59 Text en Copyright © 2009 Karapanagiotidis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Karapanagiotidis, Georgios T Antonitsis, Polychronis Charokopos, Nicholas Foroulis, Christophoros N Anastasiadis, Kyriakos Rouska, Efthymia Argiriadou, Helena Rammos, Kyriakos Papakonstantinou, Christos Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia |
title | Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia |
title_full | Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia |
title_fullStr | Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia |
title_full_unstemmed | Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia |
title_short | Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia |
title_sort | serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774681/ https://www.ncbi.nlm.nih.gov/pubmed/19886986 http://dx.doi.org/10.1186/1749-8090-4-59 |
work_keys_str_mv | AT karapanagiotidisgeorgiost serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia AT antonitsispolychronis serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia AT charokoposnicholas serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia AT foroulischristophorosn serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia AT anastasiadiskyriakos serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia AT rouskaefthymia serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia AT argiriadouhelena serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia AT rammoskyriakos serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia AT papakonstantinouchristos serumlevelsofmatrixmetalloproteinases123and9inthoracicaorticdiseasesandacutemyocardialischemia |